The Trump administration has announced an additional $250 million in aid to the Philippines, aimed at combating tuberculosis, improving maternal health, and addressing emerging disease threats. U.S. Secretary of State Marco Rubio revealed the funding on Thursday, highlighting the initiative as part of President Donald Trump’s new foreign aid strategy.
This announcement follows the $63 million commitment made during Trump’s meeting with Philippine President Ferdinand Marcos Jr. at the White House in July. Rubio emphasized that the aid reflects the “comprehensive bond between the United States and the Philippines” and showcases a more “efficient, time-limited, and narrowly targeted” America First approach to foreign assistance.
The Philippine embassy in Washington expressed appreciation for the aid but offered no further comments. The pledge underscores Washington’s continued strategic interest in strengthening bilateral ties with Manila while shifting away from traditional aid models such as USAID.
The Trump administration has consistently sought to reduce foreign assistance, attempting to withhold billions of dollars allocated by Congress as part of its broader “America First” policy. Despite these efforts, lawmakers, led by Republicans, have set aside billions in foreign aid funding, including $11 billion that must be allocated before the September 30 deadline.
After facing lawsuits, the administration agreed to release $6.5 billion in aid but continues to fight in court to block another $4 billion. The dispute is currently under review by the U.S. Supreme Court.
The latest pledge to the Philippines highlights Trump’s direct aid strategy, which prioritizes targeted investments in key areas while scaling back traditional multilateral pipelines. As Washington redefines its foreign assistance framework, the Philippines emerges as a key partner in regional health and security cooperation.


Denmark Election 2025: Social Democrats Suffer Historic Losses Amid Migration and Cost-of-Living Tensions
Russia-Iran Military Alliance Deepens With Drone Shipments Amid Middle East Tensions
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
Maduro Faces Rare Narcoterrorism Charges in U.S. Court
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Bachelet Pushes Forward With UN Secretary-General Bid Despite Chile's Withdrawal
Kristi Noem Ends Western Hemisphere Tour in Diminished Role After DHS Firing
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Trump Votes by Mail Despite Calling It "Cheating" as Democrat Wins Mar-a-Lago District
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Iran Demands Lebanon Be Part of Any Ceasefire Deal With Israel and the U.S.
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Israel Eyes Litani River as New Border Amid Escalating Lebanon Offensive
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
U.S. Deploys Elite 82nd Airborne Troops to Middle East Amid Iran Tensions 



